Key Dates

Related Announcements

December 18, 2024 - NIH Research Project Grant (Parent R01 Clinical Trial Required). See NOFO PA-25-305.

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) will withdraw its participation, effective for due dates after July 5, 2026, in PA-25-305 "NIH Research Project Grant (Parent R01 Clinical Trial Required)".

The following sections of PA-25-305 (shown in bold and italics) have been updated to reflect the withdrawal of NHLBI's participation in this Notice of Funding Opportunity (NOFO).

Part 1. Overview Information

Components of Participating Organizations

NATIONAL INSTITUTES OF HEALTH (NIH)

National Eye Institute (NEI)

National Heart, Lung, and Blood Institute (NHLBI)

National Human Genome Research Institute (NHGRI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Deafness and Other Communication Disorders (NIDCD)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Drug Abuse (NIDA)

National Institute of Environmental Health Sciences (NIEHS)

National Institute of General Medical Sciences (NIGMS)

National Institute of Mental Health (NIMH)

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute of Nursing Research (NINR)

National Institute on Minority Health and Health Disparities (NIMHD)

National Library of Medicine (NLM)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute (NCI), March 25, 2026 - Participation added (NOT-CA-26-009

Assistance Listing Number(s)

93.242, 93.867, 93.847, 93.855, 93.286, 93.879, 93.173, 93.865, 93.837, 93.853, 93.233, 93.838, 93.839, 93.840, 93.273, 93.846, 93.279, 93.859, 93.172, 93.307, 93.866, 93.361, 93.113, 93.143, 93.213, 93.393, 93.394, 93.395, 93.399

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries regarding this Notice to:

Scientific Program Contacts:

Division of Blood Diseases and Resources
Email: [email protected]
Subject: PA-25-305

Center for Translation Research and Implementation Science 
Email: [email protected] 
Subject: PA-25-305

Division of Lung Diseases 
Email: [email protected] 
Subject: PA-25-305

Division of Cardiovascular Sciences 
Email: [email protected]
Subject: PA-25-305

Grants Management Contact:
Office of Grants Management
Email: [email protected]
Subject: PA-25-305